BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
—
Last period CFO / Debt ratio ,USD
What is CFO / Debt ratio ?
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
BioNexus Gene`s CFO / Debt ratio for the last twelve months ended 2023-09-30 is —
